1. Home
  2. VUZI vs ABEO Comparison

VUZI vs ABEO Comparison

Compare VUZI & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VUZI
  • ABEO
  • Stock Information
  • Founded
  • VUZI 1997
  • ABEO 1974
  • Country
  • VUZI United States
  • ABEO United States
  • Employees
  • VUZI N/A
  • ABEO N/A
  • Industry
  • VUZI Industrial Machinery/Components
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VUZI Technology
  • ABEO Health Care
  • Exchange
  • VUZI Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • VUZI 236.4M
  • ABEO 256.9M
  • IPO Year
  • VUZI N/A
  • ABEO 1980
  • Fundamental
  • Price
  • VUZI $2.95
  • ABEO $6.16
  • Analyst Decision
  • VUZI Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • VUZI 1
  • ABEO 6
  • Target Price
  • VUZI $2.00
  • ABEO $18.00
  • AVG Volume (30 Days)
  • VUZI 2.1M
  • ABEO 1.1M
  • Earning Date
  • VUZI 05-12-2025
  • ABEO 05-15-2025
  • Dividend Yield
  • VUZI N/A
  • ABEO N/A
  • EPS Growth
  • VUZI N/A
  • ABEO N/A
  • EPS
  • VUZI N/A
  • ABEO N/A
  • Revenue
  • VUZI $5,331,630.00
  • ABEO N/A
  • Revenue This Year
  • VUZI $45.35
  • ABEO N/A
  • Revenue Next Year
  • VUZI $54.01
  • ABEO $323.51
  • P/E Ratio
  • VUZI N/A
  • ABEO N/A
  • Revenue Growth
  • VUZI N/A
  • ABEO N/A
  • 52 Week Low
  • VUZI $0.83
  • ABEO $3.93
  • 52 Week High
  • VUZI $5.79
  • ABEO $7.32
  • Technical
  • Relative Strength Index (RSI)
  • VUZI 55.12
  • ABEO 50.46
  • Support Level
  • VUZI $2.81
  • ABEO $6.10
  • Resistance Level
  • VUZI $3.43
  • ABEO $6.84
  • Average True Range (ATR)
  • VUZI 0.28
  • ABEO 0.31
  • MACD
  • VUZI -0.01
  • ABEO -0.05
  • Stochastic Oscillator
  • VUZI 47.83
  • ABEO 25.27

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: